< Directory William P. Barry

Mr. Barry regularly advises clients on a broad range of issues involving securities enforcement, white collar and securities fraud litigation, as well as compliance with Foreign Corrupt Practices Act, money laundering and insider trading requirements. 

Mr. Barry guides clients through the complex issues involved in responding to inquiries from domestic and international regulators regarding issues of accounting fraud, foreign bribery and other financial crimes. He represents clients faced with the challenge of responding to competing demands in parallel proceedings, such as internal reviews, government investigations and private civil actions. Examples of Mr. Barry's recent representations include:

• Defended a U.S. telecom in connection with parallel criminal and civil investigations by the U.S. Department of Justice and Securities and Exchange Commission regarding allegations of FCPA violations;
• Defended foreign institutions in connection with parallel investigations by the Southern District of New York U.S. Attorney's Office, Securities and Exchange Commission and Permanent Subcommittee on Investigations of the U.S. Senate;
• Represented multi-billion dollar hedge fund in connection with investigations by foreign securities regulators;
• Defended former CEO of Fortune 25 company in Securities and Exchange Commission investigation; and
• Assisted public companies, hedge funds and investment advisers in developing compliance policies to meet the requirements of the FCPA, USA-Patriot Act and other regulatory initiatives.

Mr. Barry is a member of the Steering Committee of the American Bar Association's International Anti-Money Laundering Committee and a member of the ABA's International Anti-Corruption Committee. He has been designated as a Certified Anti-Money Laundering Specialist by ACAMS, the Association of Certified Anti-Money Laundering Specialists. 

News

• Acquisition International names RK&O 2011 White-Collar Crime Law Firm of the Year
• U.S. News-Best Lawyers awards RK&O "Law Firm of the Year" in White Collar-Government Investigations Law and recognizes firm's other practice areas
• William Barry quoted in the Corporate Counsel article "Specter Blasts Fine-Only Approach to FCPA Enforcement"
• William Barry quoted in the Compliance Week article "Guidance on Bribery Act Still Disappoints"
• William Barry quoted in the Silicon Valley Mercury News article "HP Investigation Sheds Light on Challenges of the Modern Businessworld"
• William Barry quoted in Compliance Week article "DoJ Tells Pharma to Brace for FCPA"
• William Barry provides commentary in BNET article "Changing The Focus Of The Foreign Corrupt Practices Act"
• William Barry quoted in The Wall Street Journal Law Blog article "The 'Catch 22' Bust: Some Early Takeaways for FCPA Junkies"

Seminars & Speaking Engagements

• William Barry presents “Strong Medicine: Strategies for Anti-Corruption Compliance in the Pharmaceutical Industry” webinar hosted by Pharmalot
• Paul Leder and William Barry participated in roundtable discussion “International Anti-Corruption Enforcement – Impact of Regulatory Developments”
• Jeffrey Lehtman and William Barry co-host roundtable in Buenos Aires, Argentina on cross-border regulatory issues
• William Barry and Jeffrey Lehtman featured in Thomson Reuters Legal Current podcast “Money Laundering and Corruption Risks for U.S. Companies in Latin America”
• Michael Mann, Jeffrey Lehtman and William Barry co-host roundtable in Sao Paulo, Brazil on cross-border regulatory issues
• William Barry presents "FCPA and Pharma/Life Sciences...Prove Compliance, Avoid Prosecution," a webinar hosted by Aravo
• William Barry and Eric O'Meara present "Private Equity Funds, Hedge Funds and the Foreign Corrupt Practices Act: Mitigating Risk in Cross-Border Investments" via webcast
• William Barry moderates DC Bar panel discussion titled "Hot Topics in Corporate Internal Investigations"
• William Barry speaks at the New York State Bar Association Annual Meeting
• William Barry presents "Current Issues in Export Controls and the Foreign Corrupt Practices Act" at the Juris Conference on Managing Business Disputes and Legal Risk in Latin America

Publications

• "Strong Medicine: FCPA Compliance for Pharmaceutical Companies" by William Barry and Audrey Ingram published by Pharmaceutical Compliance Monitor
• "Clamping Down on Kleptocrats" by William Barry and Sarah Swanz published by Risk Management
• "Fund managers: Prepare for Bribery Act" by Carl Winkworth and William Barry published in Financial Times
• "Hedge funds and the UK Bribery Act" by Carl Winkworth and William Barry published by Hedgeweek and Private Equity Wire
• "Bracing for the Storm" by Will Barry, Sarah Swanz and Audrey Ingram published in inCompliance magazine
• "FCPA Whistleblower Bounty: Ramifications of New Provisions on Corporate Compliance" by William Barry and Audrey Laning Ingram published by Complinet
• William Barry Contributes to "U.S. and International Anti-Money Laundering Developments" in The International Lawyer
• "Navigating Anti-Bribery Restrictions to Win Business in the Global Marketplace" by William Barry and Jeffrey Lehtman
• "Compliance Strategies for Investment Businesses and Global Corporations - International Anti-Corruption Regulation" by Michael Mann and William Barry
• "Challenges For Operating Cross-Border Investment Businesses: Meeting Compliance Expectations on a Global Scale" by Michael Mann and William Barry
• "Developments in the Internationalization of Securities Enforcement Part II" by Michael Mann and William Barry
• "Developments in the Internationalization of Securities Enforcement" by Michael Mann and William Barry

Professional & Community Affiliations

• Member, ABA Anti-Money Laundering Steering Committee
• Member,  ABA International Anti-Corruption Committee
• Certified Anti-Money Laundering Specialist, Association of Certified Anti-Money Laundering Specialists